Cellmid (ASX:CDY) non-executive director Dr Edward Fintan Walton has acquired $10,640 worth of shares in the company through an on-market purchase.
This gave the PharmaVentures Ltd founder, who was appointed to the board in July 2015, an initial holding of 300,000 shares in the company.
Shares in CDY last traded at $0.036.
Earlier this week, Cellmid partnered with EAS Advisors to support expansion of its hair growth products into the U.S. hair care market, which reached sales of US$11.6 billion in 2014.
New York-based investment advisory firm EAS was founded by Eddie Sugar in 2008.
EAS recently supported Yowie Group (ASX:YOW) and Alexium International Group (ASX:AJX) with their U.S. growth plans.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.